Company Info






  Home > Past Conferences >

3rd Annual European Investigator Initiated Studies



 
Our Price: $395.00

Product Code: 2165
Qty:

  
Product Info
 
ABOUT THE CONFERENCE
Throughout Europe, Pharmaceutical & Medical Device manufacturers are eagerly working with outside investigators in order to further the knowledge and understanding of the potential uses for their products, through the conduct of investigator initiated research studies. While these studies provide invaluable data and insight into existing products, they are also an expensive undertaking and can at times cause significant strain on the manufacturer as investigators demand additional support and funds to continue research. Compounding these challenges are increasing regulatory reporting requirements and pressure from governing bodies related to the relationships between industry and healthcare professionals. The 3rd Annual European Investigator Initiated Studies Conference provided attendees with an opportunity to discuss and debate the many challenges faced by medical affairs teams as they look to not only maximize the research and outcomes from these exciting studies, but also minimize risks and costs.

PRODUCT INFORMATION:
Presentations slides are in PDF. format
All files are available for immediate download.

PRESENTATIONS INCLUDE:

DRAWING THE LINE BETWEEN INVESTIGATOR INITIATED AND SPONSOR INITIATED STUDIES
Joëlle Rebetez
IIS Manager, Global Post-Approval Operations & Medical Affairs
ACTELION PHARMACEUTICALS

CLARIFYING THE CONCEPT AND ROLE OF THE SPONSOR IN INVESTIGATOR RESEARCH
Tino Hauser
Director Clinical Affairs & Reimbursement CENEMEA
BIOTRONIK

CONNECTING INVESTIGATOR INITIATED STUDIES WITH CORPORATE MEDICAL STRATEGY
Marcus Neureither
Director Business Unit Dermatology
BIOGEN IDEC

SECURING INTELLECTUAL PROPERTY (IP) IN EUROPEAN INVESTIGATOR INITIATED STUDIES
Ina vom Feld
Partner
BIRD & BIRD

BEST PRACTICES: ESTABLISHING FAIR MARKET VALUE FOR INDIVIDUAL INVESTIGATOR INITIATED STUDIES
Micheal Ramb
Counsel
FRESHFIELDS BRUCKHAUS DERINGER

WORKSHOP: SUCCESSFULLY MANAGING EXTERNAL INVESTIGATOR PAYMENTS
Sophia Mohammad
Senior Manager Clinical Programs
EDWARDS LIFESCIENCES INTERNATIONAL

TRANSPARENCY TRENDS: CLARIFYING US & EU REGULATIONS TO ENSURE IIS COMPLIANCE
Christian Dierks
Partner

DIERKS + BOHLE ATTORNEYS

MDD REVISION: NEW CLINICAL REQUIREMENTS IMPACT ON EUROPEAN IIS
Torsten Böhler
Senior Medical Research Manager
GAMBRO DIALYSATOREN

CONTRACTING WITH EXTERNAL INVESTIGATORS: PRECISE TERMINOLOGY AND CLAUSES
Susanna Dienemann
Attorney at Law
WACHENHAUSEN RECHTSANWÄLTE

PRIORITIZING IIS COLLABORATIONS AND ALLOCATION OF FUNDS IN LIFE SCIENCE COMPANIES
Séverine Durier
Medical Affairs Manager Europe
ALCON LABORATORIES

CASE STUDY: ENSURING TIMELINES ARE MET BY THE INVESTIGATOR

Alexandra Rieben
Clinical Research Manager
NOBEL BIOCARE

UNDERSTANDING INVESTIGATOR INITIATED STUDIES FROM THE PHYSICIAN’S PERSPECTIVE

Rudolph Schopf
Director of Psoriasis Ambulatory,Senior Physician
JOHANNES GUTENBERG UNIVERSITY MAINZ

MAXIMIZE STUDY OUTCOMES THROUGH CONTINUAL IMPROVEMENT OF INTERNAL IIS STRATEGY
Klaas van’t Klooster
International Clinical Manager
DEPUY SPINE

DECLINING INVESTIGATOR INITIATED STUDIES WHILE MAINTAINING POSITIVE PHYSICIAN RELATIONSHIPS
Uli Mezger
Clinical Research Manager
BRAINLAB

Share your knowledge of this product. Be the first to write a review »